Groundbreaking Insights: Cell Culture Industry Set to Soar from 2023 to 2030

 Cell Culture Industry Data Book | Forecast 2030

Cell Culture Industry Data Book - Cell Culture, Cell Culture Media, 3D Cell Culture, Primary Cell Culture Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030

Grand View Research’s Cell Culture Industry databook is a collection of market sizing & forecasts insights, market dynamics & trends, opportunity assessment, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the databook, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.The following data points will be included in the final product offering in four reports and one sector report overview. 

 

Access the Global Cell Culture Industry Data Book, 2023 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies

 

Cell Culture Market Report Highlights

The global cell culture market size is expected to reach USD 60.27 billion by 2030, expanding at a CAGR of 11.9% from 2022 to 2030

• By consumable, the media segment accounted for the largest revenue share of over 50.0% in 2021 due to the availability of a variety of serum- and animal component-free and customized media alternatives, which has increased the market penetration for media products
• Based on product, culture systems held the largest revenue share of over 25.0% in 2021. This can be attributed to the technological advancements in automated systems for research & development applications
• The biopharmaceuticals application segment dominated the market in 2021 with a revenue share of over 25.0% due to the involvement of mammalian lines, such as the Chinese hamster ovary, in the manufacturing of biopharmaceuticals and the rising demand for non-conventional drugs
• North America held the largest revenue share in 2021 due to high research and development investments, the presence of a well-established scientific infrastructure, significant demand for animal component-free media, and other factors
• The Asia Pacific region is estimated to grow at the fastest rate over the forecast period due to the growing healthcare expenditure, rising awareness regarding regenerative therapies, and a large potential for clinical research applications

 

Order your copy of the Free Sample of “Cell Culture Industry Data Book - Cell Culture, Cell Culture Media, 3D Cell Culture, Primary Cell Culture Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030”, Data Book published by Grand View Research

 

Cell Culture Media Market Report Highlights

The global cell culture media market size is expected to reach USD 10,186.6 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.23% from 2023 to 2030.

• By product, the serum-free media segment held the largest revenue share of the market. This is attributed to the increasing gene and cell therapy research along with advantages offered by SFM, which in turn is likely to increase the adoption and anticipate market growth
• The biopharmaceutical production segment is expected to grow lucratively over the forecast period. Strategic activities by key biopharmaceutical companies, increasing R&D, demand for more reproducible and better-defined media and growing biosimilars market drives the segment growth
• By type, the liquid media segment held the largest revenue share of the market in 2022. This is attributed to increasing number of biopharmaceutical manufacturers, both downstream and upstream, are switching from premixed powders to liquid media and hence, propelling market growth
• By end-user, the pharma and biopharma companies segment held a larger share in 2022, owing to the expansion of the current manufacturing capacities coupled with increasing prevalence of chronic disease which in turn demands for novel therapeutic drugs
• North America dominated the market in 2022 due to the growth in the pharmaceutical and biotechnology industry, presence of high R&D investment, and the development of novel culture media products in the region
• In Asia Pacific, the market is expected to grow considerably in the future owing to the flourishing biosimilar medicine industry along with increasing investments by major market players to increase their presence in the region

 

3D Cell Culture Market Report Highlights

The global 3D cell culture market size is expected to reach USD 3.31 billion by 2030, expanding at 11.04% CAGR from 2023 to 2030.

• The scaffold-based technology segment dominated the market in 2022 with a revenue share of 48.85% and is attributed to the increasing application of scaffold-based cultures in tissue engineering and regenerative medicine applications
• Stem cell research & tissue engineering held the largest share of 33.76% in 2022, whereas the cancer institute segment is expected to witness the fastest growth owing to the rising prevalence of cancer, and the benefits offered by 3D cell cultures in cancer research
• In the end-use segment, biotechnology and pharmaceutical companies dominated the market with a revenue share of 46.34%. The higher revenue growth is attributed to the continuous growth and commercial success of biopharmaceuticals coupled with the expanding portfolio of the major pharmaceutical companies
• North America region dominated the global market in 2022 with a revenue share of 45.58%, owing to the presence of advanced healthcare infrastructure, developed economies, the presence of key players, and various strategic initiatives undertaken by them

 

Go through the table of content of Cell Culture Industry Data Book to get a better understanding of the Coverage & Scope of the study

 

Primary Cell Culture Market Report Highlights

The global primary cell culture market size is expected to reach USD 11.60 billion by 2030, expanding at a CAGR of 13.19% during the forecast period.

• By product, the reagent and supplements segment dominated with a share of 37.67% in 2022, due availability of a wide range of high-quality reagents and supplements tailored for specific cell types and research applications
• By separation method, the enzymatic degradation segment dominated the market with a share of 32.15% in 2022, due to the advantages of this method such as less damage to cultures, a relatively short turnaround time, and a high output of sample representation
• By cell type, the animal cells segment dominated the market with a share of 59.41% in 2022. The high growth of the segment is attributed to the versatility, wide availability, and established research protocols for this cell type
• By application, the cell & gene therapy development segment dominated the market with a share of 39.45% in 2022, due to the rapidly growing field of regenerative medicine and the increasing demand for personalized therapies
• North America established a strong regional position in the global market with a 41.52% share in 2022 due to its highly developed healthcare infrastructure and favorable government policies

 

Competitive Landscape

Competitive rivalry in the cell culture industry is high due to the presence of a large number of both well-established players and small- to mid-sized companies as well as CROs in the market space. Some of the major players are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Sartorius AG, Eppendorf AG, Merck KGaA, Becton, Dickinson and Company, PromoCell GmbH, and Lonza Group AG among many others. These market players are involved in the manufacturing of various products associated with this industry including cell media, reagents, consumables, and equipment along with certain services. To maintain a significant share in the market, key participants are undertaking various initiatives and implementing business strategies, such as product launches, product portfolio expansion, reinforcement and stabilizing the distribution network, and manufacturing capacity expansion and geographic reach expansion through acquisitions, collaborations, and partnership.

 

Check out more Industry Data Books, published by Grand View Research

 

About Grand View Research

 

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

 

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com/sector-reports-list

Follow Us: LinkedIn | Twitter